Since 2006 the Vitic Intermediates project has allowed project members to share Ames mutagenicity results (which counts for more than 99.5% of the data shared) and the results of the in vitro mammalian cell assays investigating both mutagenicity and clastogenicity of production intermediates.
Using Lhasa’s Vitic platform, Vitic Intermediates is one of several projects initiated by Lhasa Limited that enables pre-competitive data sharing.
The newly released 2020.1.0 Intermediates database contains the following data:
- New data records = 2,507
- Total data records = 30,650
- New substances = 113
- Total substances = 1,700
Constant member contributions mean that the database is ever growing. The Vitic Intermediates 2020.1.0 database now consists of 1,700 substances with 28,954 associated genetic toxicity in vitro records, of which 2,394 are new records.
Members of the Vitic Intermediates group include prominent members of the pharmaceutical industry and we are always happy to hear from interested parties. There are a number of benefits that can be achieved by joining the data sharing consortium, if you wish to find out more, please visit the Vitic Intermediates page.
To find out more about the Vitic Intermediates Project, or if you are interested in joining, please get in touch.